Compounds > n-succinimidyl 3-(trimethylstannyl)benzoate
Page last updated: 2024-09-03

n-succinimidyl 3-(trimethylstannyl)benzoate and Benign Neoplasms, Brain

n-succinimidyl 3-(trimethylstannyl)benzoate has been researched along with Benign Neoplasms, Brain in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Choi, J; Murphy, S; Pozzi, OR; Vaidyanathan, G; Zalutsky, MR; Zhao, XG1
Archer, GE; Bigner, DD; Garg, PK; Zalutsky, MR1

Other Studies

2 other study(ies) available for n-succinimidyl 3-(trimethylstannyl)benzoate and Benign Neoplasms, Brain

ArticleYear
Labeling Monoclonal Antibody with α-emitting
    Cancer biotherapy & radiopharmaceuticals, 2020, Volume: 35, Issue:7

    Topics: Alpha Particles; Animals; Antibodies, Monoclonal; Astatine; Benzoates; Brain Neoplasms; Cell Line, Tumor; Glioma; Humans; Isotope Labeling; Mice; Radioimmunotherapy; Tissue Distribution; Trimethyltin Compounds; Xenograft Model Antitumor Assays

2020
Synthesis of radioiodinated N-succinimidyl iodobenzoate: optimization for use in antibody labelling.
    International journal of radiation applications and instrumentation. Part A, Applied radiation and isotopes, 1989, Volume: 40, Issue:6

    Topics: Antibodies, Neoplasm; Benzoates; Brain Neoplasms; Iodine Radioisotopes; Isotope Labeling; Trialkyltin Compounds; Trimethyltin Compounds

1989